Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough

NewsWed, 19 Aug 2026 14:09:39 UTC2 hours ago

Moderna (MRNA) stock exploded over 100% in Wednesday pre-market trading, hitting $122.51 after the company and Merck (MRK) reported the first positive Phase 3 result for a personalized mRNA cancer vaccine.

The gain is pre-market only for now. Moderna last closed at $62.96 on Tuesday, and regular trading in New York had not yet opened at the time of writing.

Moderna Stock Rally. Source: Yahoo Finance

Follow us on X to get the latest news as it happens

A First for Personalized mRNA Cancer Therapy

The Phase 3 INTerpath-001 trial tested a bold idea. Doctors read the mutations in a patient's tumor. Moderna then builds a custom mRNA shot for that one person.

Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination… pic.twitter.com/v4DjH0r823
- Moderna (@moderna_tx) August 19, 2026

Each shot encodes up to 34 tumor targets, known as neoantigens. In effect, it teaches the immune system exactly what to hunt.

… Continue reading the full article at the original source below.

Read from Source · beincrypto.com ↗

This content is automatically aggregated. Full credit goes to the original publisher (beincrypto.com).

Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough

A First for Personalized mRNA Cancer Therapy

Related

Cuomo Urges Congress to Pass CLARITY Act Ahead of Senate Vote

Bitcoin Price Rips to $69,749: Here Is the Next Target

New cryptocurrency trends for 2026: BTC, XRP, ADA, and DOGE holders gain new opportunities through FT Mining

Jim Chanos is calling for another MSTR short